Aethlon Medical (NASDAQ:AEMD – Get Free Report) released its quarterly earnings data on Wednesday. The medical equipment provider reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.09, Zacks reports.
Aethlon Medical Stock Down 5.5 %
Shares of NASDAQ:AEMD opened at $0.63 on Friday. The company has a market capitalization of $8.81 million, a price-to-earnings ratio of -0.22 and a beta of 1.88. The firm has a 50 day moving average of $0.63 and a 200 day moving average of $0.48. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $1.85.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the company. HC Wainwright reissued a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a research report on Thursday, January 30th. StockNews.com started coverage on shares of Aethlon Medical in a report on Monday, January 27th. They set a “sell” rating on the stock.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Further Reading
- Five stocks we like better than Aethlon Medical
- What is the Euro STOXX 50 Index?
- Datadog Is in the Doghouse, But This Dip Spells Opportunity
- Pros And Cons Of Monthly Dividend Stocks
- Vertiv Stock Under Pressure: Is Opportunity Knocking?
- Why Are Stock Sectors Important to Successful Investing?
- MicroStrategy’s 8% Preferred Stock: What Investors Should Know
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
